NEK2 and non-small cell lung carcinoma: Furthermore, the high expression of NEK2/3 in NSCLC patients was significantly correlated with shorter overall survival time (OS), while the high expression of NEK1/4/6/7/8/9/10/11 mRNA in NSCLC patients was significantly correlated with good OS, which may be due to the fact that genes with high expression levels are more sensitive to treatment; hence, the prognosis is better.